Protecting pregnant women against malaria: speeding up uptake to IPTP

Globally, one in three pregnant women suffer from malaria in moderate to high transmission countries in sub-Saharan Africa. Malaria in pregnancy, or MiP, is a leading cause of maternal anemia and malaria in the fetus. It is also responsible for approximately 10,000 maternal deaths and 100,000 newborn deaths yearly.

Intermittent preventive treatment, or IPTp, started as early as possible in the second trimester and taken once each month at least three times during pregnancy, can save the lives of both expectant mothers and their unborn children from malaria, together with sleeping under a bed net and effective treatment of malaria.

Along the sidelines of the 78th United Nations General Assembly in New York, this event hosted by Devex and sponsored and convened by RBM Partnership To End Malaria will invite African First Ladies to provide leadership to the continuation of the campaign and join as champions the effort to scale up access and uptake of antenatal care services and IPTp in affected countries in Africa.

Visit the Devex website for more information and registration details.